This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Oldendorf, W. H. Articles by Braun, L. D. Search for Related Content PubMed PubMed Citation Articles by Oldendorf, W. H. Articles by Braun, L. D.

Stroke, Vol 14, 388-393, Copyright © 1983 by American Heart Association

ARTICLES

Rapid, transient drop in brain glucose after intravenous phloretin or 3- 0-methyl-D-glucose

WH Oldendorf, PD Crane, PM Lawner and LD Braun

Rats were injected intravenously with either phloretin (100 mg/kg) or 3- 0-methyl glucose (2 g/kg) to reduce the carrier-mediated flux of glucose into brain. Plasma glucose and brain free glucose (BFG), lactate, and glycogen were measured over a 16 min time course. Injection of these substances caused a rapid drop in BFG to 60% of control at one minute and a minimum (50% of control values) at 4 min., followed by a gradual rise to control levels at 16 min. While plasma glucose fell, and then increased after injection, brain lactate and glycogen content was unaffected. Repeated injections of phloretin eventually caused a drop in brain glycogen; but with either competitor, BFG never fell below 50% of normal values. The i.v. injection of the glucose analog, 3-0-methyl glucose (the less toxic of the two drugs) is proposed as a possible means of cutting off the potentially hazardous supply of blood glucose to the postischemic brain.